Skip to main content
Erschienen in: Diabetologia 12/2005

01.12.2005 | Article

Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes

verfasst von: G. Perseghin, G. Lattuada, F. De Cobelli, A. Esposito, F. Costantino, T. Canu, P. Scifo, F. De Taddeo, P. Maffi, A. Secchi, A. Del Maschio, L. Luzi

Erschienen in: Diabetologia | Ausgabe 12/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Insulin resistance may be associated with ectopic fat accumulation potentially determined by reduced lipid oxidation. In patients with type 1 diabetes peripheral insulin resistance is associated with higher intramyocellular lipid content. We assessed whether these patients are also characterised by intrahepatic fat accumulation and abnormal fat oxidation.

Methods

Nineteen patients with type 1 diabetes (6 women, 13 men, age 35±7 years, BMI 23±3 kg/m2, HbA1c 8.7±1.4%) and 19 healthy matched individuals were studied by (1) euglycaemic–hyperinsulinaemic clamp combined with [6,6−2H2]glucose infusion to assess whole–body glucose metabolism; (2) indirect calorimetry to assess glucose and lipid oxidation; and (3) localised 1H−magnetic resonance spectroscopy of the liver to assess intrahepatic fat content.

Results

Patients with type 1 diabetes showed a reduced insulin−stimulated metabolic clearance rate of glucose (4.3±1.3 ml kg−1 min−1) in comparison with normal subjects (6.0±1.6 ml kg−1 min−1; p<0.001). Endogenous glucose production was higher in diabetic patients (p=0.001) and its suppression was impaired during insulin administration (66±30 vs 92±8%; p=0.047) in comparison with normal subjects. Plasma glucagon concentrations were not different between groups. The estimated hepatic insulin concentration was lower in diabetic patients than in normal subjects (p<0.05), as was the intrahepatic fat content (1.5±0.7% and 2.2±1.0% respectively; p<0.03), the latter in association with a reduced respiratory quotient (0.74±0.05 vs 0.84±0.06; p=0.01) and increased fasting lipid oxidation (1.5±0.5 vs 0.8±0.4 mg kg−1 min−1; p<0.01).

Conclusions/interpretation

In patients with type 1 diabetes, insulin resistance was not associated with increased intrahepatic fat accumulation. In fact, diabetic patients had reduced intrahepatic fat content, which was associated with increased fasting lipid oxidation. The unbalanced hepatic glucagon and insulin concentrations affecting patients with type 1 diabetes may be involved in this abnormality of intrahepatic lipid metabolism.
Literatur
1.
Zurück zum Zitat McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766–770PubMedCrossRef McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766–770PubMedCrossRef
2.
Zurück zum Zitat Krssak M, Falk Petersen K, Dresner A et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116CrossRefPubMed Krssak M, Falk Petersen K, Dresner A et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116CrossRefPubMed
3.
Zurück zum Zitat Perseghin G, Scifo P, De Cobelli F et al. (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C NMR spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606PubMedCrossRef Perseghin G, Scifo P, De Cobelli F et al. (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C NMR spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606PubMedCrossRef
4.
Zurück zum Zitat Perseghin G, Lattuada G, Danna M et al. (2003) Insulin resistance, intramyocellular lipid content and plasma adiponectin concentrations in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285:E1174–E1181PubMed Perseghin G, Lattuada G, Danna M et al. (2003) Insulin resistance, intramyocellular lipid content and plasma adiponectin concentrations in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285:E1174–E1181PubMed
5.
Zurück zum Zitat Marchesini G, Brizi M, Bianchi G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850PubMedCrossRef Marchesini G, Brizi M, Bianchi G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850PubMedCrossRef
6.
Zurück zum Zitat Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity an normal men. J Clin Endocrinol Metab 87:3023–3028CrossRefPubMed Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity an normal men. J Clin Endocrinol Metab 87:3023–3028CrossRefPubMed
7.
Zurück zum Zitat Wohl P, Wohl P, Girman P, Pelikanova T (2004) Inflexibility of energy substrate oxidation in type 1 diabetic patients. Metabolism 53:655–659CrossRefPubMed Wohl P, Wohl P, Girman P, Pelikanova T (2004) Inflexibility of energy substrate oxidation in type 1 diabetic patients. Metabolism 53:655–659CrossRefPubMed
8.
Zurück zum Zitat Raguso CA, Coggan AR, Gastaldelli A, Sidossis LS, Bastyr EJ III, Wolfe RR (1995) Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise. Diabetes 44:1066–1074PubMedCrossRef Raguso CA, Coggan AR, Gastaldelli A, Sidossis LS, Bastyr EJ III, Wolfe RR (1995) Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise. Diabetes 44:1066–1074PubMedCrossRef
9.
Zurück zum Zitat Tuominen JA, Ebeling P, Vuorinen-Markkola H, Koivisto VA (1997) Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion. Diabet Med 14:301–308CrossRefPubMed Tuominen JA, Ebeling P, Vuorinen-Markkola H, Koivisto VA (1997) Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion. Diabet Med 14:301–308CrossRefPubMed
10.
Zurück zum Zitat Baecke JAH, Burema J, Frijters JER (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942PubMed Baecke JAH, Burema J, Frijters JER (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942PubMed
11.
Zurück zum Zitat Hother-Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3−3H-glucose infusion. Diabetologia 33:603–610CrossRefPubMed Hother-Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3−3H-glucose infusion. Diabetologia 33:603–610CrossRefPubMed
12.
Zurück zum Zitat Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat by using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495CrossRefPubMed Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat by using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495CrossRefPubMed
13.
Zurück zum Zitat Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420–431PubMedCrossRef Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420–431PubMedCrossRef
14.
Zurück zum Zitat Perseghin G, Scifo P, Danna M et al. (2002) Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. Am J Physiol Endocrinol Metab 283:E556–E564PubMed Perseghin G, Scifo P, Danna M et al. (2002) Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. Am J Physiol Endocrinol Metab 283:E556–E564PubMed
15.
Zurück zum Zitat Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212–1216PubMedCrossRef Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212–1216PubMedCrossRef
16.
Zurück zum Zitat Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H (1987) Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30:834–840PubMed Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H (1987) Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30:834–840PubMed
17.
Zurück zum Zitat Adkins-Marshall B, Pagliassotti MJ, Asher JR et al. (1992) Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am J Physiol Endocrinol Metab 262:E679–E686 Adkins-Marshall B, Pagliassotti MJ, Asher JR et al. (1992) Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am J Physiol Endocrinol Metab 262:E679–E686
18.
Zurück zum Zitat De Fronzo RA, Simonson D, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313–319PubMedCrossRef De Fronzo RA, Simonson D, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313–319PubMedCrossRef
19.
Zurück zum Zitat Lager I, Lönnroth P, Von Schenck H, Smith U (1983) Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J 287:1661–1664 Lager I, Lönnroth P, Von Schenck H, Smith U (1983) Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J 287:1661–1664
20.
Zurück zum Zitat Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906–E916PubMed Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906–E916PubMed
21.
Zurück zum Zitat Pietilainen KH, Rissanen A, Kaprio J et al. (2005) Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 288:E768–E774CrossRefPubMed Pietilainen KH, Rissanen A, Kaprio J et al. (2005) Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 288:E768–E774CrossRefPubMed
22.
Zurück zum Zitat Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycaemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608PubMedCrossRef Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycaemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608PubMedCrossRef
23.
Zurück zum Zitat McGarry JD, Foster DW (1977) Hormonal control of ketogenesis. Biochemical considerations. Arch Intern Med 137:495–501CrossRefPubMed McGarry JD, Foster DW (1977) Hormonal control of ketogenesis. Biochemical considerations. Arch Intern Med 137:495–501CrossRefPubMed
24.
Zurück zum Zitat Luzi L, Castellino P, Simonson DC, Petrides AS, DeFronzo RA (1990) Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes 39:38–48PubMedCrossRef Luzi L, Castellino P, Simonson DC, Petrides AS, DeFronzo RA (1990) Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes 39:38–48PubMedCrossRef
25.
Zurück zum Zitat Ruderman N, Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3:340–351CrossRefPubMed Ruderman N, Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3:340–351CrossRefPubMed
26.
Zurück zum Zitat Bugianesi E, Gastaldelli A, Vanni E et al. (2005) Insulin resistance in non–diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634–642CrossRefPubMed Bugianesi E, Gastaldelli A, Vanni E et al. (2005) Insulin resistance in non–diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634–642CrossRefPubMed
27.
Zurück zum Zitat Hwang JH, Perseghin G, Rothman DL et al. (1995) Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783–787PubMedCrossRef Hwang JH, Perseghin G, Rothman DL et al. (1995) Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783–787PubMedCrossRef
28.
Zurück zum Zitat Bischof MG, Krssak M, Krebs M et al. (2001) Effects of short-term improvement of insulin treatment and glycaemia on hepatic glycogen metabolism in type 1 diabetes. Diabetes 50:392–398PubMedCrossRef Bischof MG, Krssak M, Krebs M et al. (2001) Effects of short-term improvement of insulin treatment and glycaemia on hepatic glycogen metabolism in type 1 diabetes. Diabetes 50:392–398PubMedCrossRef
29.
Zurück zum Zitat Bischof MG, Bernroider E, Krssak M et al. (2002) Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycaemia. Diabetes 51:49–54PubMedCrossRef Bischof MG, Bernroider E, Krssak M et al. (2002) Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycaemia. Diabetes 51:49–54PubMedCrossRef
30.
Zurück zum Zitat Roden M, Perseghin G, Petersen KF et al. (1996) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642–648PubMed Roden M, Perseghin G, Petersen KF et al. (1996) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642–648PubMed
Metadaten
Titel
Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes
verfasst von
G. Perseghin
G. Lattuada
F. De Cobelli
A. Esposito
F. Costantino
T. Canu
P. Scifo
F. De Taddeo
P. Maffi
A. Secchi
A. Del Maschio
L. Luzi
Publikationsdatum
01.12.2005
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 12/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-0014-5

Weitere Artikel der Ausgabe 12/2005

Diabetologia 12/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.